STAAR Surgical EPS - Earnings per Share 2010-2024 | STAA
STAAR Surgical eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
STAAR Surgical Annual EPS |
2023 |
$0.43 |
2022 |
$0.80 |
2021 |
$0.56 |
2020 |
$0.12 |
2019 |
$0.30 |
2018 |
$0.11 |
2017 |
$-0.05 |
2016 |
$-0.30 |
2015 |
$-0.17 |
2014 |
$-0.22 |
2013 |
$0.01 |
2012 |
$-0.05 |
2011 |
$0.04 |
2010 |
$0.00 |
2009 |
$-0.19 |
STAAR Surgical Quarterly EPS |
2024-09-30 |
$0.20 |
2024-06-30 |
$0.15 |
2024-03-31 |
$-0.07 |
2023-12-31 |
$0.16 |
2023-09-30 |
$0.10 |
2023-06-30 |
$0.12 |
2023-03-31 |
$0.05 |
2022-12-31 |
$0.14 |
2022-09-30 |
$0.21 |
2022-06-30 |
$0.26 |
2022-03-31 |
$0.19 |
2021-12-31 |
$0.17 |
2021-09-30 |
$0.12 |
2021-06-30 |
$0.17 |
2021-03-31 |
$0.10 |
2020-12-31 |
$0.07 |
2020-09-30 |
$0.08 |
2020-06-30 |
$-0.03 |
2020-03-31 |
$-0.00 |
2019-12-31 |
$0.14 |
2019-09-30 |
$0.05 |
2019-06-30 |
$0.08 |
2019-03-31 |
$0.03 |
2018-12-31 |
$0.03 |
2018-09-30 |
$0.03 |
2018-06-30 |
$0.04 |
2018-03-31 |
$0.01 |
2017-12-31 |
$-0.01 |
2017-09-30 |
$0.03 |
2017-06-30 |
$-0.02 |
2017-03-31 |
$-0.05 |
2016-12-31 |
$-0.01 |
2016-09-30 |
$-0.04 |
2016-06-30 |
$-0.05 |
2016-03-31 |
$-0.20 |
2015-12-31 |
$-0.03 |
2015-09-30 |
$-0.04 |
2015-06-30 |
$-0.04 |
2015-03-31 |
$-0.06 |
2014-12-31 |
$-0.06 |
2014-09-30 |
$-0.07 |
2014-06-30 |
$-0.05 |
2014-03-31 |
$-0.04 |
2013-12-31 |
$-0.02 |
2013-09-30 |
$0.01 |
2013-06-30 |
$0.01 |
2013-03-31 |
$0.01 |
2012-12-31 |
$-0.05 |
2012-09-30 |
$0.00 |
2012-06-30 |
$-0.01 |
2012-03-31 |
$0.01 |
2011-12-31 |
$0.01 |
2011-09-30 |
$0.00 |
2011-06-30 |
$0.02 |
2011-03-31 |
$0.01 |
2010-12-31 |
$-0.02 |
2010-09-30 |
$-0.03 |
2010-06-30 |
$-0.05 |
2010-03-31 |
$0.10 |
2009-12-31 |
$-0.03 |
2009-09-30 |
$-0.06 |
2009-06-30 |
$-0.04 |
2009-03-31 |
$-0.06 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$1.521B |
$0.322B |
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|